Exact Mass: 520.1580688
Exact Mass Matches: 520.1580688
Found 68 metabolites which its exact mass value is equals to given mass value 520.1580688,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ethyl 4-[5-[(2-ethoxypyrimidin-5-yl)methyl]-2-[(4-fluorophenyl)methylsulfanyl]-4-oxopyrimidin-1-yl]benzoate
ethyl 4-{5-[(2-ethoxypyrimidin-5-yl)methyl]-2-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxo-1,4-dihydropyrimidin-1-yl}benzoate
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylic acid
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
Quercetin 5,7,3,4-tetramethyl ether 3-galactoside
2- (3,4-Dimethoxyphenyl) -3- (beta-D-galactopyranosyloxy) -5,7-dimethoxy-4H-1-benzopyran-4-one
Lethedoside B
5- (beta-D-glucopyranosyloxy) -7-methoxy-2- (3,4,5-trimethoxyphenyl) -4H-1-benzopyran-4-one
6-Hydroxytricetin 6,7,3,5-tetramethyl eter 5-rhamnoside
6-Hydroxytricetin 6,7,3,5-tetramethyl eter 5-rhamnoside
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
(2S,3R)-2-(1,3-benzodioxol-5-yl)-3-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydro-7-methoxybenzofuran-5-carboxylic acid methyl ester|cedralin B
(2S,3R)-2-(1,3-benzodioxol-5-yl)-3-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydro-7-methoxybenzofuran-5-carboxylic acid methyl ester|cedralin B
4-O-benzoyl-beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside
4-O-benzoyl-beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside
4-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin
4-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin
6-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin|6-O-[(E)-coumaroyl]swertiamarin
6-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin|6-O-[(E)-coumaroyl]swertiamarin
(S)-(-)-5,7,3,5-tetrahydroxyflavanone 7-O-(butyl beta-D-glucopyranosiduronate)|garccowaside B
(S)-(-)-5,7,3,5-tetrahydroxyflavanone 7-O-(butyl beta-D-glucopyranosiduronate)|garccowaside B
5-Hydroxy-7,8,2,5-tetramethoxyflavone 5-O-glucoside
5-Hydroxy-7,8,2,5-tetramethoxyflavone 5-O-glucoside
8,3-dihydroxy-3,7,4-trimethoxy-6-O-beta-D-glucopyranosyl flavone
8,3-dihydroxy-3,7,4-trimethoxy-6-O-beta-D-glucopyranosyl flavone
6-O-Cinnamoyl-8-epikingisidic acid
(1R,4aS,8S,8aS)-1-methyl-3-oxo-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-phenylprop-2-enoyl]oxymethyl]oxan-2-yl]oxy-4,4a,8,8a-tetrahydro-1H-pyrano[3,4-c]pyran-5-carboxylic acid
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
NCGC00347746-02!1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
C25H28O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,6,7,7a-hexahydro-6-hydroxy-1-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-7-methylene
NCGC00380173-01_C25H28O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,6,7,7a-hexahydro-6-hydroxy-1-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-7-methylene-
C25H28O12_(2E)-3-(2-{[6-O-(3,4,5-Trimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}phenyl)acrylic acid
NCGC00385149-01_C25H28O12_(2E)-3-(2-{[6-O-(3,4,5-Trimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}phenyl)acrylic acid
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid_major
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid_major
Cys His Met Met
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid
Cys Met His Met
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid
Cys Met Met His
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid
Asp Glu Glu Glu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-4-carboxybutanamido]pentanedioic acid
Glu Asp Glu Glu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-4-carboxybutanamido]pentanedioic acid
Glu Glu Asp Glu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-3-carboxypropanamido]pentanedioic acid
Glu Glu Glu Asp
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-4-carboxybutanamido]butanedioic acid
His Cys Met Met
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid
His Met Cys Met
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid
His Met Met Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid
Met Cys His Met
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid
Met Cys Met His
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid
Met His Cys Met
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid
Met His Met Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid
Met Met Cys His
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid
Met Met His Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid
JZL 184
4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
Nap-Nap-OH
(S)-4-(naphthalen-2-yl)-2-(3-(naphthalen-2-ylmethoxy)-4-nitrobenzamido)butanoic acid
C31H24N2O6 (520.1634283999999)
[[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]amino]-(3-ethoxy-4-hydroxyphenyl)methanesulfonic acid
[[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]amino]-(3-ethoxy-4-hydroxyphenyl)methanesulfonic acid
METHYL-3-[2-(4-AMINOBENZOYL)ACETAMINO]-4-[3,5-DICARBOXYMETHYL)-PHENOXY]-BENZOATE
METHYL-3-[2-(4-AMINOBENZOYL)ACETAMINO]-4-[3,5-DICARBOXYMETHYL)-PHENOXY]-BENZOATE
(1R,2R)-2-AMINO-CYCLOHEXANECARBOXYLICACIDETHYLESTER
(1R,2R)-2-AMINO-CYCLOHEXANECARBOXYLICACIDETHYLESTER
C28H28N2O4S2 (520.1490408000001)
(1S,2S)-2-AMINOCYCLOHEXANECARBOXYLICACID
(1S,2S)-2-AMINOCYCLOHEXANECARBOXYLICACID
C28H28N2O4S2 (520.1490408000001)
Spiradoline mesylate
Spiradoline mesylate
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
3,4,5-Trihydroxy-6-[2-[9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl]propan-2-yloxy]oxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[2-[9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl]propan-2-yloxy]oxane-2-carboxylic acid
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
(2R,3R,4R,5R)-4-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
(2R,3R,4R,5R)-4-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
Loniphenyruviridoside B, (rel)-
Loniphenyruviridoside B, (rel)-
A natural product found in Lonicera japonica.
(2r,3s,4r,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(2r,3s,4r,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
2-(3,4-dimethoxyphenyl)-5,7-dimethoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dimethoxyphenyl)-5,7-dimethoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate